
EdenRoc Sciences: A private biotech firm managing a portfolio of innovative bioscience and pharmaceutical startups.
EdenRoc Sciences, founded as a private biotechnology firm, focuses on managing and nurturing a portfolio of innovative bioscience and pharmaceutical startups. Its core mission is to address the diseases of aging by leveraging novel science and intellectual property licensed from top universities. EdenRoc's subsidiaries operate autonomously, offering products and services that range from genomic detection and clinical-stage pharmaceuticals to forensics and biologic-based consumer products. The company aims to foster longer, healthier lives through its diverse and cutting-edge scientific endeavors.
Notable affiliated companies under EdenRoc Sciences include Dovetail Genomics, Arc Bio, Metro International Biotech, Liberty Biosecurity, Revere Biosensors, and Claret Biosciences. These subsidiaries benefit from shared resources and collaboration, facilitated by EdenRoc's centralized support in legal, human resources, finance, and other core business functions. EdenRoc's impact is significant in the life sciences sector, driving advancements in genomics, pharmaceuticals, and biosecurity through its innovative portfolio and strategic partnerships.
Companies similar to EdenRoc Sciences include Rejuveron Life Sciences, Rubedo Life Sciences, Arc Bio and Roivant Sciences.
EdenRoc Sciences was founded in 2016.
EdenRoc Sciences' headquarters is located in Cambridge, MA, US.
EdenRoc Sciences' most recent funding round was for $55.5M (USD) in December 2023.
As of Dec 26, 2023, EdenRoc Sciences has disclosed funding of $229.4M (USD). Undisclosed round amounts are excluded.
EdenRoc Sciences has 175 employees as of Feb 5, 2024.
Roivant Sciences
roivant.com